Silence Therapeutics plc
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
11. Capital commitments and contingent liabilities
There wereno capital commitments at September 30, 2025 or 2024.
- Restructuring charges
The Group initiated a non-recurring reduction in workforce which resulted in total restructuring charges of $1.3 million in the three months ended June 30, 2025. The charges consist of severance costs for terminated employees. The remaining accrual at September 30, 2025 was $0.2 million.
- Related party transactions
None.
- Subsequent events
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.